“…[1] Though PDT has been apromising option for cancer treatment owing to its non-invasiveness,t he photosensitizer still faces many barriers,s uch as poor water-solubility,non-selectivity,and poor biocompatibility,restricting the use of PDT in clinical practice. [2] To overcome these limitations,n anocarriers [2] such as polymer nanoparticles, [3] liposomes, [4] dendrimers, [5] and inorganic nanoparticles [6] or other kind nanoparticles, [7] have been developed for the delivery of these hydrophobic drugs to prolong blood circulation and enhance the accumulation of drugs in tumor tissues by the enhanced permeation and retention (EPR) effect. [8] Thedelivery efficiencyofhydrophobic drugs,such as photosensitizers,i se nhanced by the nanocarriers,b ut many limitations still exist, such as premature leakage and nonselective release of photosensitizers.…”